Newsroom

LONDON--(BUSINESS WIRE)--KBRA UK (KBRA) is pleased to announce the assignment of preliminary ratings to five classes of UK Logistics 2026-4 DAC, a CMBS single-borrower transaction. The collateral for the transaction is a £613.7 million limited recourse, first lien mortgage loan expected to be originated by Barclays Bank PLC in September 2026. The floating-rate loan is expected to have an initial two-year term and three one-year extension options. The loan is secured by the borrower’s freehold (...

WASHINGTON--(BUSINESS WIRE)--Az EIG a globális energia- és infrastruktúraszektor egyik vezető intézményi befektetője, a mai napon 1,9 milliárd dolláros tőkeösszeggel bejelentette az EIG Senior Infrastructure Debt Fund VI („SIDF VI”) végleges lezárását, ami az előző alap összegének közel kétszerese. Az egyetlen befektető számára létrehozott konstrukciókba („single investor vehicles”) lekötött 2,1 milliárd dollárral együtt ez az összeg meghaladja a stratégia eredetileg 3 milliárd dolláros célkitű...

México, Ciudad de México--(BUSINESS WIRE)--AM Best ha revisado las perspectivas a positivas de estables y ha afirmado la Calificación de Fortaleza Financiera (FSR, por sus siglas en inglés) de A- (Excelente) y la Calificación Crediticia de Emisor (ICR, por sus siglas en inglés) de Largo Plazo de “a-” (Excelente) de Genesis Global Re Limited (Génesis) (Nassau, Bahamas). Las Calificaciones Crediticias (calificaciones) reflejan la importancia estratégica de Génesis como subsidiaria de La Colonial,...

MEXICO CITY--(BUSINESS WIRE)--AM Best has revised the outlooks to positive from stable and affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” (Excellent) of Genesis Global Re Limited (Genesis) (Nassau, Bahamas). The Credit Ratings (ratings) reflect Genesis’ strategic importance as a subsidiary of La Colonial, S.A. - Compañía de Seguros (La Colonial), which on a consolidated basis, has a balance sheet strength that AM Best assesses as stronges...

PARIGI--(BUSINESS WIRE)--BioLife ha annunciato oggi che lo United States Patent and Trademark Office ha concesso il brevetto statunitense 12,667,605 B2 alla sua innovativa tecnologia di somministrazione orale effervescente dei peptidi, sviluppata per supportare le terapie peptidiche attuali e future per l’obesità, il diabete e le malattie metaboliche. L'annuncio coincide con un momento di rapida crescita della domanda di farmaci a base di GLP-1. Nel 2025, le terapie a base di GLP-1 hanno genera...

NEW YORK--(BUSINESS WIRE)--MidOcean Partners (“MidOcean” or the “Firm”), a premier New York-based alternative asset manager specializing in middle market private equity, alternative credit and structured equity, announced the signing of the sale of SI Solutions, Inc. and its subsidiaries (collectively, “SI” or the “Company”) to a Macquarie Asset Management-led consortium (“Macquarie”). SI Solutions is a leading provider of engineering, testing and software solutions to critical infrastructure e...

KANSAS CITY, Mo. & PALM CITY, Fla.--(BUSINESS WIRE)--Herzig Engineering, a leading provider of electrical safety and reliability services, today announced the acquisition of Brady Infrared, a respected infrared inspection services provider based in Florida. Herzig Engineering is backed by Copley Equity Partners. Financial terms of the transaction were not disclosed. Brady Infrared has over 25 years of experience providing comprehensive infrared inspection and ancillary services across a variety...

SUNNYVALE, Calif.--(BUSINESS WIRE)--Knightscope, Inc. (NASDAQ: KSCP), the security technology company building the nation’s first Autonomous Security Force, today published “The Security Agent,” the third field brief in its series, ahead of the Force’s live debut at GSX 2026, the Global Security Exchange, Booth #3905, September 14-16, 2026, at the Georgia World Congress Center in Atlanta. The Field Brief makes the case that the guard industry’s headcount model is broken and presents an alternat...

PARÍS--(BUSINESS WIRE)--BioLife ha anunciado hoy que la United States Patent and Trademark Office ha concedido la patente estadounidense n.º 12.667.605 B2 por su novedosa tecnología de administración oral efervescente de péptidos, diseñada para complementar los tratamientos actuales y futuros con péptidos para la obesidad, la diabetes y las enfermedades metabólicas. El anuncio se produce en un momento en el que la demanda de medicamentos con GLP-1 sigue creciendo a un ritmo acelerado. Las terap...

PARIJS--(BUSINESS WIRE)--BioLife maakte vandaag bekend dat de United States Patent & Trademark Office het Amerikaanse octrooi 12,667,605 B2 heeft toegekend voor zijn nieuwe technologie voor bruisende orale toediening van peptiden, ontworpen om huidige en toekomstige peptidentherapieën voor obesitas, diabetes en stofwisselingsstoornissen te ondersteunen. Deze aankondiging wordt gedaan op een moment dat de vraag naar GLP-1-geneesmiddelen blijft toenemen. GLP-1-therapieën genereerden om en bij...